These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31689473)

  • 21. ER-mediated anti-tumor effects of shikonin on breast cancer.
    Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
    Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
    Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
    J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1.
    Hirao-Suzuki M; Nagase K; Suemori T; Tsutsumi K; Shigemori E; Tanaka M; Takiguchi M; Sugihara N; Yoshihara S; Takeda S
    Biol Pharm Bull; 2021; 44(10):1524-1529. PubMed ID: 34602561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.
    Tilghman SL; Sabnis G; Brodie AM
    Horm Mol Biol Clin Investig; 2010 Dec; 3(1):357-66. PubMed ID: 25961207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
    Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium.
    Welsh T; Johnson M; Yi L; Tan H; Rahman R; Merlino A; Zakar T; Mesiano S
    J Endocrinol; 2012 Feb; 212(2):227-38. PubMed ID: 22068927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM; Korach KS
    Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.
    Williams MM; Lee L; Werfel T; Joly MMM; Hicks DJ; Rahman B; Elion D; McKernan C; Sanchez V; Estrada MV; Massarweh S; Elledge R; Duvall C; Cook RS
    Cell Death Dis; 2018 Jan; 9(2):21. PubMed ID: 29343814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
    Yu X; Filardo EJ; Shaikh ZA
    Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
    Gonzalez TL; Hancock M; Sun S; Gersch CL; Larios JM; David W; Hu J; Hayes DF; Wang S; Rae JM
    Breast Cancer Res Treat; 2020 Apr; 180(3):611-622. PubMed ID: 32067153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival.
    Tilghman SL; Sabnis G; Brodie AM
    Horm Mol Biol Clin Investig; 2011 Jan; 3(1):357-366. PubMed ID: 23606920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of silver nanoparticles on proliferation of estrogen-dependent MCF-7/BUS human breast cancer cells induced by butyl paraben or di-n-butyl phthalate.
    Roszak J; Smok-Pieniążek A; Domeradzka-Gajda K; Grobelny J; Tomaszewska E; Ranoszek-Soliwoda K; Celichowski G; Stępnik M
    Toxicol Appl Pharmacol; 2017 Dec; 337():12-21. PubMed ID: 29074358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.
    Bourque M; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.